Search

Displaying results 8761 - 8770 of 10000 in total
  1. Drug

    Bucainide

    go.drugbank.com/drugs/DB20650
    Experimental

    The usage of the INN stem '-cain-' in the name indicates that Bucainide is a class I antiarrhythmic, procainamide and lidocaine derivative. Bucainide has a monoisotopic molecular weight of 329.28 Da.

  2. Drug

    Milacainide

    go.drugbank.com/drugs/DB20252
    Experimental

    The usage of the INN stem '-cain-' in the name indicates that Milacainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  3. Drug

    VH3739937

    go.drugbank.com/drugs/DB25287
    Investigational

    is under investigation in clinical trial NCT06533280 (VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and

  4. Drug

    Tanogitran

    go.drugbank.com/drugs/DB21367
    Investigational

    Tanogitran is under investigation in clinical trial NCT02254057 (Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects).

  5. Drug

    Masofaniten

    go.drugbank.com/drugs/DB21580
    Investigational

    Masofaniten is under investigation in clinical trial NCT06312670 (Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer).

  6. Drug

    Arginine glutamate

    go.drugbank.com/drugs/DB13207
    Investigational

    Categories: Bile and Liver Therapy, Alimentary Tract and Metabolism
  7. Drug

    Propenidazole

    go.drugbank.com/drugs/DB13319
    Experimental

    Categories: Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics
  8. Drug

    BGB-DXP593

    go.drugbank.com/drugs/DB16357
    Investigational

    the clinical trial NCT04551898 (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)) by

  9. Drug

    Pocenbrodib

    go.drugbank.com/drugs/DB21616
    Investigational

    Pocenbrodib is under investigation in clinical trial NCT06785636 (Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617).

  10. Drug

    COCAINE ESTERASE (RBP-8000)

    go.drugbank.com/drugs/DB19225
    Investigational

    RBP-8000 is under investigation in clinical trials (A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse) for the treatment of Cocaine Abuse.

    Categories: Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins